# About peptidesinburleson — An Independent Recovery-Research Desk > About peptidesinburleson: an independent literature digest on the Wolverine blend (BPC-157 + TB-500) and its constituent research peptides. How it is compiled, and what it is not — not a seller, not a clinic, not medical advice. An independent, citation-anchored digest of the recovery-peptide literature. Not a vendor. Not a clinic. Not medical advice. ## What peptidesinburleson is peptidesinburleson is an independent editorial reference desk covering the published research on three entries in the tissue-repair peptide space: the **Wolverine blend** (BPC-157 + TB-500) as the lead concept, and its two constituent research peptides — BPC-157 and TB-500 — as individual compound pages. The site exists to make a scattered, frequently overstated, and technically demanding literature legible: to tell a reader, in precise language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches. The organizing concept is the Wolverine blend itself — two peptides paired on the theory that their mechanisms complement each other, a proposition that is scientifically interesting but, as of the current literature, unconfirmed by any controlled study. Understanding what BPC-157 and TB-500 each actually do in animals, and where their evidence thins out, is the precondition for evaluating the blend honestly. Each compound has its own page, a comparison page lines them up side by side, and a single shared reference list aggregates every source. ## Editorial method The desk draws exclusively on peer-reviewed sources: PubMed-indexed journal articles, systematic reviews, narrative reviews, clinical trial records, and formal pharmacokinetic studies. Every claim on a compound page is linked to a numbered reference that identifies the authors, journal, year, PubMed ID, and DOI where available. A single [references list](/references) compiles the full set across all pages. Where the evidence is preclinical (animal or cell-culture), we say so. Where it comes from a single research group, we note the independent-replication limitations. Where community-reported effects are described — anecdotal accounts from research-use communities — they are labeled explicitly as **anecdotal, not clinical evidence** and separated from the literature findings. We do not present anecdote as though it equals study data, and we do not present study data as though it applies directly to human experience. No human dose is stated anywhere on this desk. No regimen is recommended. No product is promoted or sold. This site does not make medical claims and does not constitute medical advice. ## What this site is not peptidesinburleson is not affiliated with any peptide supplier, compounding pharmacy, or commercial entity. It does not sell products. It does not name or link to specific suppliers. It does not provide clinical recommendations. There is no author bio, no practitioner claim, no office address, and no appointment booking — because none of those things exists here. "Burleson" in the name is a brand identifier, not a location claim; this is an editorial digest, not a local service. Readers seeking medical advice should consult a licensed healthcare provider who can evaluate their specific clinical situation. The desk makes no claim to substitute for that relationship, and the research summaries here should be read as maps of the published science, not as treatment guides. --- An independent literature digest: citations, mechanisms, and honest evidence limits — never doses, never products.